1. Successful sequential drug eluting balloon angioplasty to chronic total occluded popliteal artery in a patient with thromboangitis obliterans by PCR
- Author
-
Adnan Kaya, Aysel Yazıcı, and Fehmi Kaçmaz
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Intermittent pneumatic compression ,Case Report ,030204 cardiovascular system & hematology ,Thromboangitis Obliterans ,03 medical and health sciences ,Peripheral Arterial Disease ,0302 clinical medicine ,Internal medicine ,medicine.artery ,Angioplasty ,medicine ,Humans ,Popliteal Artery ,030212 general & internal medicine ,Angioplasty, Balloon, Coronary ,Vascular Patency ,business.industry ,Thromboangiitis Obliterans ,Popliteal artery ,Bosentan ,Cilostazol ,Surgery ,Femoral Artery ,Treatment Outcome ,Cardiology ,Cardiology and Cardiovascular Medicine ,Drug eluting balloon ,business ,Angioplasty, Balloon ,medicine.drug ,Iloprost - Abstract
Thromboangitis obliterans (TAO), also known as Buerger’s disease (BD), is a non-atherosclerotic, segmental, inflammatory, episodic, non-destructive, thrombotic, and occlusive disease of unknown origin compromising small to medium-sized distal arteries, veins, and nerves (1). Intravenous iloprost (2), intermittent pneumatic compression (3), bosentan (4), and cilostazol (5) are used or experimental medical therapies for TAO, for all that smoking cessation is the sole definitive therapy. Surgical revascularization is usually not preferred because of high involvement of distal segments of vessels. Endovascular revascularization could be an option for patients with bad distal vasculature. Case Report
- Published
- 2016